Intensive tobacco treatment for cancer patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of an intensive tobacco treatment program for cancer patients who smoke, measuring cessation success rates at 30 days, 3 months, and 6 months. It employs a mixed-methods, observational cohort approach, where eligible patients at the NCCC are offered carbon monoxide monitoring as part of their treatment. The study compares the cessation rates of those receiving intensive treatment to those receiving usual care and historical controls, without randomization or blinding.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adults age 18 and older
* Active Smoker at the time of initial consultation for cancer (defined as any smoking within 2 weeks of consult)

Exclusion Criteria:

* Adults unable to consent
* Prisoners

Where it's running

• Dartmouth-Hitchcock Medical Center
  Lebanon, New Hampshire, United States Recruiting

Study contacts

• Principal investigator: Joseph D Phillips, MD — Dartmouth-Hitchcock Medical Center
• Study coordinator: Joseph D Phillips, MD
• Email: Joseph.D.PHillips@hitchcock.org
• Phone: 603-650-8537

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• One extra structured CBT session to help cancer patients quit smoking

  This trial tests whether adding one CBT-based smoking-cessation session to standard brief counseling helps cancer patients quit smoking cigarettes.

  Recruiting Vietnam National Cancer Hospital · Hanoi · NCT07822464

• Relapse-prevention counseling added to standard care for cancer patients who quit smoking at diagnosis

  This trial tests whether adding one structured CBT-based relapse-prevention session helps cancer patients who have remained smoke-free since diagnosis stay abstinent longer.

  Recruiting Vietnam National Cancer Hospital · Hà Nội · NCT07815912

• Automating Tobacco Cessation in Primary Care

  This project tests a workflow in primary care to identify smokers and help them access nicotine replacement therapy (NRT) during routine visits.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07735286

• Text2Quit-Kenya: a mobile message program to help ED patients quit tobacco

  Researchers will test a text message-based smoking-cessation program with Kenyan emergency department patients to see if it helps people quit and learn what works in this setting.

  Recruiting Yale University · Nairobi · NCT07734727

• How people puff IQOS Iluma i vs IQOS 2.4 and how flavors feel

  This study tests how exclusive IQOS users puff the newer Iluma i versus the older 2.4, and whether preferred flavor affects puffing and sensory experience.

  Recruiting at 2 sites American University of Beirut Medical Center · Beirut, Beirut and 1 other locations · NCT07712887

• Feasibility of a perinatal smoking and cannabis cessation program

  This study tests a perinatal program to help pregnant people quit tobacco and cannabis and stay smoke-free after birth.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT07489443

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.